ITMI
Cancer Research Spotlights Innovation
Inova grants foster cutting-edge studies with power to transform care When potentially deadly melanoma spreads, growing numbers of patients are offered immunotherapy to unleash the immune system’s power to kill cancer cells. But only some cancer patients respond to immunotherapy — perplexing doctors hoping to rein in the threat. Now Inova scientists are among the…
Read MoreHow Cardiovascular Genetic Testing Makes a Difference
Inova helps one family manage gene-influenced heart disease For decades, Stephen Aldo, now 62, was diagnosed with an “insignificant” heart murmur — nothing serious enough to affect his career with the United States Marine Corps. However, while stationed in Japan in 1984, a routine physical uncovered a disease that ultimately ended his military career. Stephen…
Read MoreNPR Visits Inova to Document Infant-Health Research Study
Inova’s vaginal seeding study featured on NPR’s Morning Edition NPR’s Morning Edition has profiled the groundbreaking vaginal seeding study at Inova Women’s Hospital that aims to discover if babies born by C-section will benefit from a swab of their mother’s microbes. The article explains how vaginal seeding “was developed in response to the sharp rise…
Read MoreGenetic testing & counseling helped guide this breast cancer patient’s journey
Family Matters Genetic testing and counseling help guide a Northern Virginia wife and mother’s decisions about her breast cancer treatment When Nicole Sharabi, 42, tested positive last year for stage 3, triple-negative breast cancer, she was ready to take action. But before beginning any medical treatment, Nicole underwent genetic testing. “I wanted as much information…
Read MoreImmunotherapy: Cancer Care Gets Customized
Timothy L. Cannon, MD, is board certified in medical oncology and hematology, and has a special interest in managing gastrointestinal cancers. Dr. Cannon is the clinical director and moderator of Inova’s weekly molecular tumor board, which matches patients with targeted therapies based on molecular diagnostics. Tiffani A. DeMarco, MS, CGC, is a board-certified…
Read MoreInova: Uncovering Breakthrough Insights that Help Save Lives Cloudera
With Cloudera Enterprise, Inova researchers can answer questions magnitudes faster than they could previously to help the organization realize its goal of delivering precision medicine. Watch more.
Read MoreTwo Va. research powerhouses come together on projects with seed fund, Washington Business Journal
Inova Health System and University of Virginia are kicking off their new partnership with $450,000 in seed money to fund nine joint research projects geared toward better predicting, preventing and treating disease. Read more.
Read MoreGenetic Counselors In Growing Demand as Genetic Testing Takes Off
Benjamin D. Solomon leads the Medical Genomics Division at the Inova Translational Medicine Institute. He performs genome-based research to find the causes of patients’ genetic disorders and is also involved in the clinical care of patients with genetic conditions. He is board certified in clinical genetics and pediatrics. Read Dr. Solomon’s profile. Last year, a…
Read MoreFecal Transplants Bring Gut Bacteria Into Balance
Suchi Hourigan, MD, is board certified in pediatric gastroenterology. She treats children of all ages and has a particular interest in the gut microbiome, nutrition and disorders of the intestines. She’s also the director of microbiome research at the Inova Translational Medicine Institute, where she studies the role of gut bacteria in human health and…
Read MoreInova Embraces Obama Administration “Moonshot” to Cure Cancer Initiative by Naming Thomas P. Conrads, PhD, to Cancer Research Team
FALLS CHURCH, VA – January 21, 2016 – At last week’s State of the Union address, President Obama brought renewed resolve to the fight to cure cancer, acknowledging that the scientific community is on the brink of significant break-throughs. He called for additional research, more funding, and collaboration among health systems, academic research institutions, private industry,…
Read More